KRAS and carcinoma: Only the MTORC1 pathway, among all of the pathways involved in the adenoma–carcinoma sequence (WNT β-catenin, KRAS signaling up, MTORC1, and TGF-β pathways), was enriched in CRC organoids of the GSE 57965 cohort.